Evolent Health (EVH) stock price, revenue, and financials

Evolent Health market cap is $694.9 m, and annual revenue was $846.38 m in FY 2019

$694.9 M

EVH Mkt cap, 22-May-2020

$846.4 M

Evolent Health Revenue FY, 2019
Evolent Health Net income (FY, 2019)-302 M
Evolent Health EBIT (FY, 2019)-306.6 M
Evolent Health Cash, 31-Dec-2019101 M
Evolent Health EV956.4 M

Evolent Health Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

96.9m254.2m435.0m627.1m846.4m

Revenue growth, %

162%

General and administrative expense

75.3m160.7m205.7m235.4m257.0m

Operating expense total

75.3m160.7m205.8m235.5m257.5m

Depreciation and amortization

7.2m17.2m32.4m44.5m60.9m

EBIT

(43.0m)(237.4m)(72.8m)(47.5m)(306.6m)

EBIT margin, %

(44%)(93%)(17%)(8%)(36%)

Interest expense

293.0k723.0k

Interest income

1.7m3.4m4.0m

Investment income

(28.2m)(841.0k)(1.8m)(9.5m)

Pre tax profit

(25.2m)343.3m(237.5m)(76.4m)(54.2m)(327.1m)

Income tax expense

23.5m(10.8m)(6.6m)40.0k(21.5m)

Net Income

(25.2m)332.5m(159.7m)(60.7m)(52.7m)(302.0m)

Evolent Health Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

145.7m134.6m238.4m228.3m101.0m

Accounts Receivable

20.4m40.6m48.9m80.2m75.7m

Prepaid Expenses

4.2m11.0m8.4m22.6m28.5m

Current Assets

1.1k184.5m265.0m378.2m488.0m228.8m

PP&E

12.8m31.2m50.9m73.6m85.2m

Goodwill

608.9m626.6m628.2m768.1m572.1m

Total Assets

37.2k1.0b1.2b1.3b1.7b1.5b

Accounts Payable

16.7m43.9m42.9m146.8m37.5m

Current Liabilities

59.5m131.9m132.7m269.4m192.8m

Long-term debt

120.3m121.4m221.0m362.5m

Total Debt

120.3m121.4m221.0m362.5m

Total Liabilities

1.1k80.9m287.7m266.4m532.9m569.0m

Common Stock

415.0k506.0k

Additional Paid-in Capital

23.7k342.1m555.3m924.2m1.1b1.2b

Retained Earnings

(25.8k)306.7m146.6m86.0m50.0m(252.0m)

Total Equity

(2.1k)934.6m912.1m1.0b1.2b929.0m

Debt to Equity Ratio

0.1 x

Debt to Assets Ratio

0.1 x

Financial Leverage

-18 x1.1 x1.3 x1.3 x1.4 x1.6 x

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

219.4m208.2m111.3m105.1m109.8m104.3m100.0m287.1m200.3m198.0m221.8m170.8m92.8m96.7m

Accounts Receivable

24.0m30.5m25.2m30.3m22.0m44.6m45.8m44.0m66.1m70.8m60.1m65.6m71.4m74.9m

Prepaid Expenses

3.2m3.5m4.2m5.3m5.0m11.7m12.6m16.1m17.4m15.8m14.7m30.5m32.8m29.7m

Current Assets

251.6m246.2m167.6m170.6m191.4m217.5m192.6m352.3m337.3m353.3m348.6m321.2m240.9m308.0m

PP&E

8.5m10.8m15.5m18.5m21.1m35.5m40.2m46.9m60.4m64.6m68.7m77.4m80.2m83.2m

Goodwill

608.9m608.9m459.7m459.7m459.7m627.2m628.7m628.3m635.2m635.3m635.1m770.3m772.2m771.9m

Total Assets

1.0b1.1b856.5m852.8m851.3m1.2b1.1b1.3b1.3b1.3b1.3b1.6b1.7b1.7b

Accounts Payable

13.5m12.6m17.0m12.4m14.5m39.6m26.3m27.3m22.4m34.3m30.5m39.0m28.8m120.0m

Current Liabilities

60.8m89.8m52.5m56.7m65.3m104.4m101.8m105.5m116.9m136.2m139.4m163.7m172.9m259.9m

Long-term debt

120.7m120.9m121.2m121.6m121.9m122.1m280.5m296.4m298.6m

Total Debt

120.7m120.9m121.2m121.6m121.9m122.1m280.5m296.4m298.6m

Total Liabilities

91.1m120.1m80.8m84.7m91.4m257.7m243.9m243.3m251.4m270.2m274.1m479.2m505.5m589.6m

Additional Paid-in Capital

330.8m335.3m357.0m361.9m397.6m621.2m747.4m920.0m953.3m961.5m971.3m1.1b1.2b1.2b

Retained Earnings

322.8m310.8m183.9m175.2m164.0m128.6m111.7m99.1m89.0m79.1m66.7m3.3m(28.3m)(53.9m)

Total Equity

948.7m936.1m775.7m768.1m759.9m896.7m894.4m1.1b1.1b1.1b1.0b1.2b1.1b1.1b

Debt to Equity Ratio

0.1 x0.1 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.1 x1.1 x1.1 x1.1 x1.1 x1.3 x1.3 x1.2 x1.2 x1.3 x1.3 x1.4 x1.4 x1.5 x

Evolent Health Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(25.2m)319.8m(226.8m)(69.8m)(54.2m)(305.6m)

Depreciation and Amortization

7.2m17.2m32.4m44.5m60.9m

Accounts Receivable

11.8m(11.0m)(11.3m)

Accounts Payable

2.8m(6.4m)5.6m7.6m(5.5m)

Cash From Operating Activities

145.7m(35.5m)(28.0m)(20.7m)(42.6m)

Purchases of PP&E

(6.5m)(15.5m)(27.8m)(39.5m)(35.5m)

Cash From Investing Activities

(43.7m)(97.8m)(12.3m)(160.4m)(181.6m)

Cash From Financing Activities

207.9m122.1m165.6m274.0m(35.5m)

Net Change in Cash

145.7m(11.2m)125.3m93.0m(259.8m)

Evolent Health Ratios

USDY, 2019

EV/EBIT

-3.1 x

EV/CFO

-22.4 x

Revenue/Employee

248.9k

Financial Leverage

1.6 x

Evolent Health Operating Metrics

FY, 2015Q1, 2016Q2, 2016FY, 2016Q1, 2017Q2, 2017

Lives on the Platform

718 k1.25 m1.40 m2 m2.80 m2.80 m

Locations

30 30

Partners

11 25 25 25

Evolent Health Employee Rating

2.9603 votes
Culture & Values
2.9
Work/Life Balance
3.2
Senior Management
2.5
Salary & Benefits
3.4
Career Opportunities
2.8
Source